Indeed, CD204 showed high correlation with immune checkpoints, especially TIM‐3 and PD‐1, suggesting the possible synergy of CD204+ TAMs and immune checkpoint regulators in inhibiting the function of T cells in glioma. This evidence concerns the gene MSR1 and glioma.